tiprankstipranks
Sensei Biotherapeutics (SNSE)
NASDAQ:SNSE
US Market

Sensei Biotherapeutics (SNSE) Financial Statements

Compare
191 Followers

Sensei Biotherapeutics Financial Overview

Sensei Biotherapeutics's market cap is currently $11.94M. The company's EPS TTM is $-1.188; its P/E ratio is ―; Sensei Biotherapeutics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -571.00K$ -1.81M$ -685.00K$ -209.00K$ -73.00K
Operating Income$ -37.06M$ -50.19M$ -37.48M$ -19.45M$ -12.44M
EBITDA$ -33.39M$ -46.56M$ -36.80M$ -18.50M$ -12.36M
Net Income$ -34.10M$ -48.81M$ -37.46M$ -20.63M$ -19.00M
Balance Sheet
Cash & Short-Term Investments$ 65.76M$ 17.80M$ 147.62M$ 16.60M$ 251.00K
Total Assets$ 74.37M$ 118.38M$ 153.22M$ 21.43M$ 1.22M
Total Debt$ 6.21M$ 8.03M$ 2.35M$ 567.00K$ 16.05M
Net Debt$ -6.80M$ -9.76M$ -4.80M$ -16.03M$ 15.80M
Total Liabilities$ 9.48M$ 14.97M$ 6.71M$ 77.87M$ 69.88M
Stockholders' Equity$ 64.89M$ 103.41M$ 146.51M$ -56.44M$ -68.66M
Cash Flow
Free Cash Flow$ -32.20M$ -39.35M$ -32.28M$ -18.91M$ -8.62M
Operating Cash Flow$ -32.02M$ -39.03M$ -30.26M$ -17.70M$ -8.57M
Investing Cash Flow$ 38.41M$ 49.95M$ -143.12M$ -1.40M$ -53.00K
Financing Cash Flow$ -11.17M$ -287.00K$ 163.94K$ 35.45M$ 8.22M
Currency in USD

Sensei Biotherapeutics Earnings and Revenue History

Sensei Biotherapeutics Debt to Assets

Sensei Biotherapeutics Cash Flow

Sensei Biotherapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis